Loading...
XKRX118000
Market cap32mUSD
Dec 24, Last price  
288.00KRW
1D
-1.71%
1Q
-23.20%
Jan 2017
-97.36%
IPO
-95.87%
Name

The MediPharm Co Ltd

Chart & Performance

D1W1MN
XKRX:118000 chart
P/E
—
P/S
0.85
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
32.54%
Rev. gr., 5y
10.09%
Revenues
55.75b
+191.91%
3,427,010,00029,404,109,00034,386,311,97022,314,787,65012,465,767,03011,762,225,96011,450,627,55011,232,856,46036,880,327,35034,471,966,03056,155,488,90026,895,986,46018,613,345,27019,098,326,97055,750,068,750
Net income
-14.54b
L-82.32%
343,970,000-2,738,016,000-12,527,851,250-6,406,158,930-4,562,578,000-8,846,494,000-7,593,662,000-8,620,667,000-2,908,727,000-12,042,294,450-4,042,868,66011,252,452,7607,739,922,840-82,220,156,450-14,540,250,000
CFO
-12.86b
L+408.38%
-292,680,0001,288,185,0001,267,776,7101,493,406,930258,121,110-5,221,728,080-3,558,414,880-4,851,448,730-12,687,553,540-2,708,019,6201,244,910,3803,794,995,860-1,491,580,510-2,529,059,620-12,857,231,290

Profile

Wooridul Huebrain Limited engages in the medical, life and health, pharmaceutical, and storage businesses. It sells medical equipment and appliances, health equipment, medicines, and computer servers. Wooridul Huebrain Limited was formerly known as Wooridul Life Sciences Limited and changed its name to Wooridul Huebrain Limited in April 2014. Wooridul Huebrain Limited was founded in 2009 and is based in Seoul, South Korea.
URL
http://www.chorokbaemhc.com/
IPO date
Dec 30, 2009
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
55,750,069
191.91%
19,098,327
2.61%
18,613,345
-30.80%
Cost of revenue
60,029,759
16,761,766
16,203,671
Unusual Expense (Income)
NOPBT
(4,279,690)
2,336,561
2,409,674
NOPBT Margin
12.23%
12.95%
Operating Taxes
(154,289)
32,665,440
(2,358,917)
Tax Rate
1,398.01%
NOPAT
(4,125,402)
(30,328,879)
4,768,591
Net income
(14,540,250)
-82.32%
(82,220,156)
-1,162.29%
7,739,923
-31.22%
Dividends
Dividend yield
Proceeds from repurchase of equity
2,995,964
17,888,362
35,686,942
BB yield
-7.10%
-40.99%
-24.24%
Debt
Debt current
3,139,790
24,488,337
29,678,028
Long-term debt
1,020,657
11,852,236
431,589
Deferred revenue
Other long-term liabilities
788,846
492,481
3,446,072
Net debt
(88,733,992)
(72,783,177)
(109,612,683)
Cash flow
Cash from operating activities
(12,857,231)
(2,529,060)
(1,491,581)
CAPEX
(5,382,493)
(166,193)
(29,977)
Cash from investing activities
8,826,756
(36,720,554)
11,853,258
Cash from financing activities
(4,358,901)
8,485,877
34,169,194
FCF
(2,827,179)
(51,420,923)
6,159,219
Balance
Cash
22,400,888
29,739,870
59,236,307
Long term investments
70,493,552
79,383,881
80,485,992
Excess cash
90,106,936
108,168,834
138,791,632
Stockholders' equity
29,372,093
22,285,269
26,071,809
Invested Capital
112,474,877
142,679,415
126,475,258
ROIC
4.22%
ROCE
1.41%
1.58%
EV
Common stock shares outstanding
105,511
83,915
97,812
Price
400.00
-23.08%
520.00
-65.45%
1,505.00
-40.40%
Market cap
42,204,368
-3.28%
43,635,693
-70.36%
147,207,477
21.17%
EV
(9,176,940)
12,332,179
37,594,794
EBITDA
454,910
4,298,499
3,922,580
EV/EBITDA
2.87
9.58
Interest
3,322,822
5,546,135
7,633,775
Interest/NOPBT
237.36%
316.80%